INVO Bioscience Inc.

NASDAQ: INVO · Real-Time Price · USD
0.83
-0.02 (-2.35%)
At close: Oct 21, 2024, 10:00 PM

INVO Bioscience Revenue

INVO Bioscience reported an annual revenue of $6.53B, reflecting a 216150.22% growth. For the quarter ending June 30, 2025, INVO Bioscience generated $1.86B in revenue.
Revenue (ttm)
6.53B
Revenue Growth
216150.22%
Price / Sales Ratio
0
Revenue / Employee
261.28M
Employees
25
Market Cap
3.25M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 6.53B +216150.22%
Dec 31, 2023 3.02M +267.38%
Dec 31, 2022 822.2K -80.24%
Dec 31, 2021 4.16M +301.06%
Dec 31, 2020 1.04M -29.92%
Dec 31, 2019 1.48M +199.41%
Dec 31, 2018 494.38K +75.22%
Dec 31, 2017 282.14K +454.30%
Dec 31, 2016 50.9K +335.46%
Dec 31, 2015 11.69K -29.53%
Dec 31, 2014 16.59K -38.71%
Dec 31, 2013 27.06K -52.00%
Dec 31, 2012 56.38K -21.15%
Dec 31, 2011 71.5K +5.70%
Dec 31, 2010 67.65K +7.03%
Dec 31, 2009 63.2K +66.35%
Dec 31, 2008 37.99K +Infinity%
Dec 31, 2007 0 n/a
Dec 31, 2006 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.